Regeneron Pharmaceuticals
REGN
#250
Rank
S$121.77 B
Marketcap
S$1,177
Share price
1.73%
Change (1 day)
38.17%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): S$50.35

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is S$53.63. In 2022 the company made an earnings per share (EPS) of S$51.85 a decrease over its 2021 EPS that were of S$97.83.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S$50.35-2.9%
2022S$51.85-47%
2021S$97.83133.36%
2020S$41.9269.13%
2019S$24.79-14.44%
2018S$28.97100.71%
2017S$14.4331.78%
2016S$10.9538.96%
2015S$7.8872.55%
2014S$4.57-17.55%
2013S$5.54-44.98%
2012S$10.07-422.54%
2011S-$3.1292.13%
2010S-$1.6349.41%
2009S-$1.09-15.84%
2008S-$1.29-36.88%
2007S-$2.05-9.6%
2006S-$2.264.12%
2005S-$2.18-323.68%
2004S$0.97-135.51%
2003S-$2.74-24.38%
2002S-$3.6256.35%
2001S-$2.32187.3%
2000S-$0.81-16%
1999S-$0.96177.78%
1998S-$0.35-35.71%
1997S-$0.54-68.42%
1996S-$1.70

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.55-84.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$6.72-87.47%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
S$20.76-61.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$2.44-95.46%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$3.02-94.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$25.35-52.73%๐Ÿ‡บ๐Ÿ‡ธ USA